Blocking the mTOR-Myc-DC-SIGN axis in acinar cells might be a therapeutic intervention approach by balancing local CD4+ T-cell-mediated pro-inflammatory and anti-inflammatory responses during AP. The gene discussed is MYC; the disease is alkaline phosphatase measurement.